Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
2'-O-acetylsalicortin is a naturally occurring salicinoid glycoside isolated from Salix pseudolasiogyne (a willow species). It has been identified as a bioactive phytochemical with notable anti-adipogenic effects. In vitro studies show that it significantly suppresses lipid accumulation in differentiating adipocytes by inhibiting the expression of key lipogenic and adipogenic transcription factors at both mRNA and protein levels. This suggests potential utility in metabolic disease research, particularly for obesity-related conditions[5][1]. Its mechanism appears to involve modulation of gene expression related to fat cell development rather political direct enzyme inhibition.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 2'-O-acetylsalicortin.